VERVE THERAPEUTICS INC (VERV) Stock Balance Sheet
NASDAQ:VERV - Nasdaq - US92539P1012 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 158.71M | 206.18M | 115.40M | 64.30M | 9.00M | |||
| Marketable Securities | 381.21M | 417.77M | 439.40M | 296.10M | 63.10M | |||
| Receivables | 2.63M | 5.90M | 1.00M | N/A | N/A | |||
| Other Current Assets | 13.91M | 8.10M | 7.30M | 6.70M | 1.90M | |||
| Total Current Assets | 556.46M | 637.95M | 563.20M | 367.10M | 74.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 99.55M | 107.80M | 110.70M | 9.10M | 4.00M | |||
| Other Non-Current Assets | 7.90M | 6.94M | 5.40M | 7.90M | 500.00K | |||
| Total Non-Current Assets | 107.45M | 114.74M | 116.00M | 17.00M | 4.40M | |||
| TOTAL ASSETS | 663.91M | 752.69M | 679.20M | 384.10M | 78.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 32.29M | 30.37M | 32.70M | 14.90M | 7.20M | |||
| Accounts Payable | 4.64M | 6.64M | 2.40M | 7.10M | 0.00 | |||
| Other Current Liabilities | 5.72M | N/A | N/A | 0.00 | 100.00K | |||
| Total Current Liabilities | 42.64M | 37.01M | 35.10M | 22.00M | 7.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 112.71M | 116.18M | 93.20M | 4.70M | 9.80M | |||
| Total Non-Current Liabilities | 112.71M | 116.18M | 93.20M | 4.80M | 9.90M | |||
| TOTAL LIABILITIES | 155.35M | 153.19M | 128.30M | 26.80M | 17.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -692.98M | -544.30M | -344.20M | -186.90M | -66.50M | |||
| Additional Paid In Capital | 1.20B | 1.14B | 895.80M | 544.40M | 2.60M | |||
| Common Shares | 85.00K | 82.00K | 100.00K | 0.00 | 125.20M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | 357.35M | N/A | |||
| Shares Outstanding | 84.64M | 81.97M | 61.70M | 48.50M | 46.10M | |||
| Tangible Book Value per Share | 6.01 | 7.31 | 8.93 | 7.37 | -1.39 | |||
| Total Shareholders' Equity | 508.55M | 599.50M | 550.90M | 357.40M | 61.30M | |||
| TOTAL LIABILITIES AND EQUITY | 663.91M | 752.69M | 679.20M | 384.10M | 78.40M | |||
| Statistics | ||||||||
| Current Ratio | 13.05 | 17.24 | 16.05 | 16.69 | 10.14 | |||
| Return On Assets (ROA) | -29.68% | -26.58% | -23.17% | -31.32% | -58.29% | |||
| Return On Equity (ROE) | -38.74% | -33.37% | -28.57% | -33.66% | -74.55% | |||
All data in USD , ROIC based on taxRate of 0.21